ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at […]
On Feb 7 2020 MGEN a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies announced a $15 Million Public offering of […]
Advaxis, Inc. (ADXS) (the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products. Here is a short term trade Idea […]
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical stage gene therapy company today announced it has entered into securities purchase agreements with institutional investors for […]
Copyright © 2020 | WordPress Theme by TodayTrader